Sutro Biopharma (STRO) Prepaid Assets (2017 - 2025)
Sutro Biopharma recorded quarterly Prepaid Assets of $5.5 million in Q4 2025, down 47.9% quarter-over-quarter from $10.6 million in Q3 2025, and down 68.98% year-over-year from $17.8 million in Q4 2024.
Sutro Biopharma's Prepaid Assets history runs 9 years deep, the most recent figure standing at $5.5 million for Q4 2025.
- In Q4 2025, Prepaid Assets fell 68.98% year-over-year to $5.5 million; the TTM figure through Dec 2025 stood at $5.5 million (down 68.98% YoY), while the FY2025 annual figure was $5.5 million, down 68.98% from the prior year.
- Prepaid Assets came in at $5.5 million for Q4 2025 at Sutro Biopharma, down from $10.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $24.9 million in Q1 2025 to a low of $5.5 million in Q4 2025.
- A 5-year average of $11.5 million and a median of $10.2 million in 2023 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets surged 232.69% in 2021 and slumped 68.98% in 2025, its largest moves.
- Sutro Biopharma's Prepaid Assets stood at $8.1 million in 2021, then surged by 43.63% to $11.7 million in 2022, then decreased by 15.61% to $9.8 million in 2023, then jumped by 80.77% to $17.8 million in 2024, then slumped by 68.98% to $5.5 million in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $5.5 million, $10.6 million, and $18.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sutro Biopharma | 242.87 Mn | 242.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.52 Mn |
| Sep 30, 2025 | 10.60 Mn |
| Jun 30, 2025 | 18.50 Mn |
| Mar 31, 2025 | 24.88 Mn |
| Dec 31, 2024 | 17.80 Mn |
| Sep 30, 2024 | 10.87 Mn |
| Jun 30, 2024 | 10.53 Mn |
| Mar 31, 2024 | 10.06 Mn |
| Dec 31, 2023 | 9.85 Mn |
| Sep 30, 2023 | 9.48 Mn |
| Jun 30, 2023 | 10.34 Mn |
| Mar 31, 2023 | 17.70 Mn |
| Dec 31, 2022 | 11.67 Mn |
| Sep 30, 2022 | 11.06 Mn |
| Jun 30, 2022 | 8.20 Mn |
| Mar 31, 2022 | 7.91 Mn |
| Dec 31, 2021 | 8.12 Mn |
| Sep 30, 2021 | 8.70 Mn |
| Jun 30, 2021 | 9.75 Mn |
| Mar 31, 2021 | 7.55 Mn |
| Dec 31, 2020 | 4.49 Mn |
| Sep 30, 2020 | 3.58 Mn |
| Jun 30, 2020 | 2.93 Mn |
| Mar 31, 2020 | 2.99 Mn |
| Dec 31, 2019 | 4.41 Mn |
| Sep 30, 2019 | 2.87 Mn |
| Jun 30, 2019 | 2.56 Mn |
| Mar 31, 2019 | 2.63 Mn |
| Dec 31, 2018 | 2.97 Mn |
| Sep 30, 2018 | 1.98 Mn |
| Dec 31, 2017 | 1.99 Mn |